TFA
RPRX icon

Transamerica Financial Advisors’s Royalty Pharma RPRX Stock Holding History

Transamerica Financial Advisors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$358K Buy
6,380
+286
+5% +$14.9K 0.03% 335
2026
Q1 		$292K Buy
6,094
+936
+18% +$41K 0.02% 346
2025
Q4 		$199K Buy
5,158
+498
+11% +$19K 0.02% 366
2025
Q3 		$164K Buy
4,660
+4,643
+27,312% +$168K 0.01% 353
2025
Q2 		$604 Sell
17
-1,419
-99% -$47K ﹤0.01% 427
2025
Q1 		$45K Sell
1,436
-496
-26% -$15.7K ﹤0.01% 312
2024
Q4 		$50K Sell
1,932
-1,527
-44% -$40.5K ﹤0.01% 314
2024
Q3 		$98K Buy
3,459
+1,729
+100% +$47.9K 0.01% 274
2024
Q2 		$46K Hold
1,730
– – ﹤0.01% 278
2024
Q1 		$53K Sell
1,730
-6,633
-79% -$196K 0.01% 300
2023
Q4 		$235K Sell
8,363
-2,234
-21% -$61.4K 0.03% 233
2023
Q3 		$288K Sell
10,597
-1,430
-12% -$42.5K 0.04% 197
2023
Q2 		$370K Sell
12,027
-2,990
-20% -$101K 0.05% 194
2023
Q1 		$542K Buy
15,017
+3,147
+27% +$117K 0.07% 170
2022
Q4 		$470K Buy
11,870
+203
+2% +$8.47K 0.07% 171
2022
Q3 		$469K Sell
11,667
-1,247
-10% -$53.3K 0.07% 166
2022
Q2 		$543K Buy
+12,914
New +$529K 0.08% 161

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transamerica Financial Advisors's RPRX Position: Q2 2026 in Review

Transamerica Financial Advisors increased its Royalty Pharma (RPRX) stake by 4.7% in Q2 2026, buying an estimated $14.9K and bringing the position to 6,380 shares worth $358K. The position accounts for 0.03% of the portfolio, ranked #335.

Transamerica Financial Advisors first reported a position in RPRX in Q2 2022 and has held it in 17 quarters since. The position peaked at $543K in Q2 2022. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Transamerica Financial Advisors held 6,380 shares of Royalty Pharma worth $358K as of Q2 2026.
  • Transamerica Financial Advisors bought 286 Royalty Pharma shares in Q2 2026, an estimated $14.9K.
  • Royalty Pharma made up 0.03% of Transamerica Financial Advisors's portfolio in Q2 2026, its #335 holding.
  • Transamerica Financial Advisors first reported a position in Royalty Pharma in Q2 2022 and has held it in 17 quarters since.
  • Transamerica Financial Advisors's Royalty Pharma position peaked at $543K in Q2 2022.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.